A comprehensive view of The Lancet. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Mitsubishi Tanabe Pharma Corp. publishes positive results from Phase 3 clinical study of ND0612 for Parkinson's disease treatment in The Lancet Neurology; NeuroDerm Ltd. conducted the study
Published: March 20, 2024 by ENP Newswire
Novavax Inc. - R21/Matrix-M™ Malaria Vaccine Phase 3 Trial Results Published in The Lancet
Published: February 02, 2024 by U.S. Markets (Alternative Disclosure) via PUBT
R21/Matrix-M™ Malaria Vaccine Phase 3 Trial Results Published in The Lancet
Published: February 02, 2024 by Novavax Inc.
AbbVie reports oral Ubrevy 100 mg significantly reduces the likelihood of developing moderate or severe headaches when administered during a migraine's prodrome phase; nearly 40 million in US are affected by migraines
Published: November 16, 2023 by AbbVie Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count